Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 2/20 | 0.35 |
| ▸ | DRD2 | P14416 | 3/20 | 0.33 |
| ▸ | DRD4 | P21917 | 3/20 | 0.33 |
| ▸ | DRD3 | P35462 | 3/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.33 |
| ▸ | CCR5 | P51681 | 1/20 | 0.33 |
| ▸ | DRD1 | P21728 | 1/20 | 0.31 |
| ▸ | DRD5 | P21918 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6858183 | 0.86 | CCR1 (0.38) | CCR1CHRM2CCR5 | |
| SCHEMBL653266 | 0.82 | CCR1 (0.55) | CCR1DRD2DRD4DRD3CHRM1 | |
| SCHEMBL653265 | 0.82 | CCR1 (0.55) | CCR1DRD2DRD4DRD3CHRM1 | |
| SCHEMBL6859736 | 0.79 | CCR1 (0.49) | CCR1CHRM2CCR5 | |
| SCHEMBL6861133 | 0.73 | CCR1 (0.48) | CCR1CHRM2CCR5 | |
| SCHEMBL3250560 | 0.72 | CCR1 (0.50) | CCR1CHRM2CCR5 | |
| SCHEMBL15478316 | 0.70 | CCR1 (0.58) | CCR1DRD2DRD3CHRM2CCR5 | |
| SCHEMBL5703572 | 0.70 | CCR1 (0.58) | CCR1CHRM2CCR5 | |
| SCHEMBL6859353 | 0.69 | CCR1 (0.41) | CCR1DRD2DRD4CHRM2CCR5 | |
| SCHEMBL14703479 | 0.69 | CCR1 (0.60) | CCR1CHRM2CCR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1448566-A2 | CHEMOKINE RECEPTOR ANTAGONISTS AND METHODS OF USE THEREOF | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2004-08-25 | — | — | EP | disclosed |
| WO-2003045942-A2 | CHEMOKINE RECEPTOR ANTAGONISTS AND METHODS OF USE THEREOF | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2003-06-05 | — | — | WO | disclosed |